1. Home
  2. ECPG vs AXGN Comparison

ECPG vs AXGN Comparison

Compare ECPG & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Encore Capital Group Inc

ECPG

Encore Capital Group Inc

HOLD

Current Price

$68.96

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Axogen Inc.

AXGN

Axogen Inc.

HOLD

Current Price

$31.30

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECPG
AXGN
Founded
1998
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
1999
2013

Fundamental Metrics

Financial Performance
Metric
ECPG
AXGN
Price
$68.96
$31.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$77.33
$37.63
AVG Volume (30 Days)
255.6K
739.8K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
287.14
N/A
EPS
10.91
N/A
Revenue
$1,768,802,000.00
$225,208,000.00
Revenue This Year
$4.53
$20.31
Revenue Next Year
$4.76
$16.36
P/E Ratio
$6.31
N/A
Revenue Growth
34.37
20.21
52 Week Low
$26.45
$9.22
52 Week High
$74.58
$36.00

Technical Indicators

Market Signals
Indicator
ECPG
AXGN
Relative Strength Index (RSI) 57.13 47.18
Support Level $65.01 $30.34
Resistance Level $74.58 $34.25
Average True Range (ATR) 2.17 1.42
MACD -0.33 0.09
Stochastic Oscillator 55.45 31.52

Price Performance

Historical Comparison
ECPG
AXGN

About ECPG Encore Capital Group Inc

Encore Capital Group Inc is an international specialty finance company engaged in providing debt recovery solutions and other related services for consumers across a broad range of financial assets. It mainly purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals to repay their obligations and work toward financial recovery. The company also provides debt servicing and other portfolio management services to credit originators for non-performing loans in Europe. It has only one reportable segment, debt purchasing and recovery. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Europe, and other regions.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

Share on Social Networks: